Glycogen Synthase Kinase-3 Is Required For Transforming Growth Factor-²-induced Myofibroblast Differentiation

Author(s):  
Hoeke A. Baarsma ◽  
Lilian H.J.M. Engelbertink ◽  
Dirkje S. Postma ◽  
Wim Timens ◽  
Herman Meurs ◽  
...  
2013 ◽  
Vol 288 (27) ◽  
pp. 19370-19385 ◽  
Author(s):  
Alexander S. Shavkunov ◽  
Norelle C. Wildburger ◽  
Miroslav N. Nenov ◽  
Thomas F. James ◽  
Tetyana P. Buzhdygan ◽  
...  

1994 ◽  
Vol 303 (1) ◽  
pp. 27-31 ◽  
Author(s):  
Y Saito ◽  
J R Vandenheede ◽  
P Cohen

Glycogen synthase kinase 3 (GSK3) was inhibited by 50% within 5 min when A431 cells were stimulated with epidermal growth factor (EGF). The inhibition was unaffected by rapamycin at concentrations which blocked the activation of p70 S6 kinase, and reversed by incubation with protein phosphatase-1. EGF stimulation of A431 cells inhibited GSK3 alpha and GSK3 beta to a similar extent, and inhibition was accompanied by phosphorylation of the tryptic peptides containing the serine residues phosphorylated in vitro by p70 S6 kinase or MAP kinase-activated protein (MAPKAP) kinase-1 beta (also termed Rsk-2). These results demonstrate that EGF inhibits GSK3 by inducing phosphorylation of a serine residue and that GSK3 is not phosphorylated in vivo by either p70 S6 kinase or protein kinase C.


Sign in / Sign up

Export Citation Format

Share Document